Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One year of Use-A Single Center Retrospective Cohort Study.

Panos LD, Scutelnic A, Plüss SE, Bracher J, Rossel JB, Branca M, Riederer F, Schankin CJ

Open source

DOI
10.2147/dddt.s567680
Published
2026
Container
Drug design, development and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s567680,
  title = {Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One year of Use-A Single Center Retrospective Cohort Study.},
  author = {Panos LD and Scutelnic A and Plüss SE and Bracher J and Rossel JB and Branca M and Riederer F and Schankin CJ},
  year = {2026},
  journal = {Drug design, development and therapy},
  doi = {10.2147/dddt.s567680},
  url = {https://doi.org/10.2147/dddt.s567680}
}

RIS

TY  - JOUR
TI  - Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One year of Use-A Single Center Retrospective Cohort Study.
AU  - Panos LD
AU  - Scutelnic A
AU  - Plüss SE
AU  - Bracher J
AU  - Rossel JB
AU  - Branca M
AU  - Riederer F
AU  - Schankin CJ
PY  - 2026
JO  - Drug design, development and therapy
DO  - 10.2147/dddt.s567680
UR  - https://doi.org/10.2147/dddt.s567680
ER  - 

APA

LD, P., A, S., SE, P., J, B., JB, R., M, B., F, R., & CJ, S. (2026). Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One year of Use-A Single Center Retrospective Cohort Study.. Drug design, development and therapy. https://doi.org/10.2147/dddt.s567680

Source records